Connect with the Top 50 Epidemic Prevention Companies from Taiwan
With the success in combating the COVID pandemic, The Taiwan Healthcare Expo is the only live healthcare event toward the end of the year, for those who can not attend …
Read MoreThe Next Generation Biotech Media
With the success in combating the COVID pandemic, The Taiwan Healthcare Expo is the only live healthcare event toward the end of the year, for those who can not attend …
Read MoreAlnylam Pharmaceuticals, a Massachusetts-based leading RNAi therapeutics company, announced on November 24th the approval of OXLUMO (lumasiran), the first-ever therapy meant for lowering oxalate levels in children and adults suffering from …
Read MoreOn November 21st, the F.D.A issued an emergency use authorization (EUA) for Regeneron Pharmaceuticals Inc.’s COVID-19 antibody cocktail therapy and became the first in the United States or Europe to …
Read MoreOn November 17th, global biotech D3 Bio launched with a $200 million Series A financing by Boyu Capital, Matrix Partners China, Wuxi AppTech, Temasek, and Sequoia. The funding will support …
Read MoreOn November 20th, Eli Lilly and Precision BioSciences announced a research collaboration to develop therapies for genetic disorders using Precision’s genome editing technology, ARCUS. The agreement includes an exclusive license …
Read MoreNovember 20th, 2020 – Australia-based Mesoblast Limited entered into a $50 M deal with pharma giant Novartis for the development, manufacture, and commercialization of Mesoblast’s mesenchymal stromal cell (MSC) product …
Read MoreIn a bid to push Merrimack’s dropout drug seribantumab through Phase 2, Elevation Oncology has raised $65 M in a Series B financing round, led by new investors venBio Partners …
Read MoreNovember 19, 2020 – With more than 55 million people infected, and over 1.3 million deaths, the coronavirus pandemic has ravaged the world unlike any other in recent memory. The …
Read MoreOn November 17th, a long-term partnership was signed between Samsung Biologics and Eli Lilly to manufacture the latter’s COVID-19 antibody treatments. Samsung said it delivered an initial supply of active …
Read MoreNovember 18, 2020 – TwinStrand Biosciences has announced today its entry into an agreement to sublicense two foundational patent families to Cambridge, MA-based Foundation Medicine (FMI). This agreement offers FMI …
Read More